STAT Plus: Lawmakers’ coronavirus response means delays for drug pricing legislation
SUSAN WALSH/AP
Lawmakers, lobbyists, and drug pricing advocates saw May as a final opportunity this year to pass drug pricing legislation.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario